op 2507 has been researched along with taurocholic acid in 1 studies
| Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (taurocholic acid) | Trials (taurocholic acid) | Recent Studies (post-2010) (taurocholic acid) |
|---|---|---|---|---|---|
| 33 | 0 | 1 | 3,789 | 26 | 654 |
| Protein | Taxonomy | op 2507 (IC50) | taurocholic acid (IC50) |
|---|---|---|---|
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 6 | |
| Sodium/bile acid cotransporter | Rattus norvegicus (Norway rat) | 6 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, T; Kawarada, Y; Yokoi, H | 1 |
1 other study(ies) available for op 2507 and taurocholic acid
| Article | Year |
|---|---|
The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Epoprostenol; Injections, Subcutaneous; Kidney; Lung; Male; Methacrylates; Pancreas; Pancreatitis, Acute Necrotizing; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1998 |